LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming investor conferences:
Craig-Hallum 23rd Annual Institutional Investor Conference
1x1 meetings only
Date: Thursday, May 28, 2026
Location: Minneapolis, MN
William Blair 46th Annual Growth Stock Conference
Presentation and 1x1 meetings
Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT
Location: Chicago, IL
TD Cowen Annual Tools/Dx Revolution
1x1 meetings only
Date: Wednesday, June 24, 2026
Location: Dana Point, CA
The presentation will be webcast live and available for replay under “News & Events” in the Investors section of Biodesix's website at Biodesix.com.
About Biodesix:
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, including Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.
Biodesix Contacts:
Media:
Natalie St. Denis, Director Corporate Communications
natalie.stdenis@biodesix.com
(720) 925-9285
Investors:
Chris Brinzey, Partner, ICR
chris.brinzey@icrhealthcare.com
(339) 970-2843
